• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型吡唑啉酮查耳酮的合成、分子对接及生物学研究

Synthesis, molecular docking, and biological investigations of new pyrazolone chalcones.

作者信息

Noser Ahmed A, Salem Maha M, ElSafty Esraa M, Baren Mohamed H, Selim Adel I, Mandour Hamada S A

机构信息

Organic Chemistry, Chemistry Department, Faculty of Science, Tanta University Tanta 31527 Egypt

Biochemistry Division, Chemistry Department, Faculty of Science, Tanta University Tanta 31527 Egypt

出版信息

RSC Adv. 2025 Apr 25;15(17):13214-13224. doi: 10.1039/d5ra01233c. eCollection 2025 Apr 22.

DOI:10.1039/d5ra01233c
PMID:40290744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12023741/
Abstract

Heterocyclic compounds are essential to the drug development and discovery processes. Herein, we synthesized new pyrazolone chalcones (3a-g) through the reaction of azopyrazolone (2) with different aromatic aldehydes in a basic medium. Numerous techniques including elemental analysis, H-NMR, C-NMR, and FT-IR spectroscopies, were used to characterize pyrazolone chalcone derivatives. Compound 3b exhibited the highest binding energy towards YAP/TEAD protein with a value of -8.45 kcal mol in studies. This observation suggested that compound 3b inhibits the YAP/TEAD Hippo signaling pathway. In addition, compound 3b offered a prospective anticancer effect against various cancer cell lines, such as HepG-2, MCF-7, and HCT-116, among the other synthesized compounds, with IC values equal to 5.03 ± 0.4, 3.92 ± 0.2, and 6.34 ± 0.5 μM, respectively. These results validated our findings regarding the suppression of the YAP/TEAD protein. Its pharmacokinetic properties were theoretically observed using ADMET. Additionally, compound 3b demonstrated a potent antioxidant scavenging action () against DPPH free radicals. Thus, based on our findings, compound 3b may act as a potential anticancer scaffold owing to its inhibitory impact towards the YAP/TEAD-mediated Hippo signaling pathway with a safe toxic profile on normal cells.

摘要

杂环化合物对药物开发和发现过程至关重要。在此,我们通过偶氮吡唑啉酮(2)与不同芳香醛在碱性介质中的反应合成了新型吡唑啉酮查耳酮(3a - g)。使用了包括元素分析、H - NMR、C - NMR和FT - IR光谱等多种技术来表征吡唑啉酮查耳酮衍生物。在研究中,化合物3b对YAP/TEAD蛋白表现出最高的结合能,值为 - 8.45 kcal/mol。这一观察结果表明化合物3b抑制YAP/TEAD Hippo信号通路。此外,在其他合成化合物中,化合物3b对多种癌细胞系,如HepG - 2、MCF - 7和HCT - 116,具有预期的抗癌作用,IC值分别等于5.03±0.4、3.92±0.2和6.34±0.5 μM。这些结果验证了我们关于YAP/TEAD蛋白抑制作用的发现。使用ADMET理论上观察了其药代动力学性质。此外,化合物3b对DPPH自由基表现出有效的抗氧化清除作用()。因此,基于我们的发现,化合物3b可能因其对YAP/TEAD介导的Hippo信号通路的抑制作用以及对正常细胞安全的毒性特征而作为一种潜在的抗癌支架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/b810d804e54d/d5ra01233c-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/81b96f857ad7/d5ra01233c-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/629f2944444a/d5ra01233c-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/24477fac147c/d5ra01233c-s2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/ba50cbfef4e7/d5ra01233c-s3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/537713570d42/d5ra01233c-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/0a6ec01afa0d/d5ra01233c-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/4cdffecf26e6/d5ra01233c-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/e50f3955e74c/d5ra01233c-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/f40178b7575f/d5ra01233c-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/b810d804e54d/d5ra01233c-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/81b96f857ad7/d5ra01233c-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/629f2944444a/d5ra01233c-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/24477fac147c/d5ra01233c-s2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/ba50cbfef4e7/d5ra01233c-s3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/537713570d42/d5ra01233c-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/0a6ec01afa0d/d5ra01233c-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/4cdffecf26e6/d5ra01233c-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/e50f3955e74c/d5ra01233c-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/f40178b7575f/d5ra01233c-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6180/12023741/b810d804e54d/d5ra01233c-f7.jpg

相似文献

1
Synthesis, molecular docking, and biological investigations of new pyrazolone chalcones.新型吡唑啉酮查耳酮的合成、分子对接及生物学研究
RSC Adv. 2025 Apr 25;15(17):13214-13224. doi: 10.1039/d5ra01233c. eCollection 2025 Apr 22.
2
Discovering the inhibition of YAP/TEAD Hippo signaling pathway via new pyrazolone derivatives: synthesis, molecular docking and biological investigations.发现新型吡唑啉酮衍生物对 YAP/TEAD Hippo 信号通路的抑制作用:合成、分子对接和生物学研究。
Sci Rep. 2024 Nov 21;14(1):28859. doi: 10.1038/s41598-024-79992-x.
3
Inhibition of DRP-1 mitochondrial mitophagy and fission by novel α-aminophosphonates bearing pyridine: synthesis, biological evaluations, and computer-aided design.含吡啶新型α-氨基膦酸酯对DRP-1线粒体自噬和裂变的抑制作用:合成、生物学评价及计算机辅助设计
BMC Chem. 2024 Sep 18;18(1):174. doi: 10.1186/s13065-024-01268-2.
4
Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines.新型查尔酮-噻吩嘧啶衍生物在 HepG2 和 MCF-7 细胞系中的合成、抗癌评估和分子对接。
Oxid Med Cell Longev. 2021 Dec 28;2021:4759821. doi: 10.1155/2021/4759821. eCollection 2021.
5
Pyrazoline analogs as potential anticancer agents and their apoptosis, molecular docking, MD simulation, DNA binding and antioxidant studies.吡唑啉类似物作为潜在的抗癌剂及其细胞凋亡、分子对接、MD 模拟、DNA 结合和抗氧化研究。
Bioorg Chem. 2021 Mar;108:104665. doi: 10.1016/j.bioorg.2021.104665. Epub 2021 Jan 27.
6
Chalcones bearing nitrogen-containing heterocyclics as multi-targeted inhibitors: Design, synthesis, biological evaluation and molecular docking studies.含氮杂环查尔酮类化合物作为多靶点抑制剂的设计、合成、生物评价及分子对接研究。
J Mol Recognit. 2023 Jul;36(7):e3020. doi: 10.1002/jmr.3020. Epub 2023 May 5.
7
Design, synthesis, spectroscopic characterizations, single crystal X-ray analysis, xanthine oxidase and acetylcholinesterase inhibitory evaluation as well as evaluation of selenium-based -heterocyclic carbene compounds.设计、合成、光谱特性、单晶 X 射线分析、黄嘌呤氧化酶和乙酰胆碱酯酶抑制评估以及硒基 -杂环卡宾化合物的评估。
J Biomol Struct Dyn. 2023;41(21):11728-11747. doi: 10.1080/07391102.2022.2163696. Epub 2023 Jan 9.
8
Imidazole-Derived Alkyl and Aryl Ethers: Synthesis, Characterization, In Vitro Anticancer and Antioxidant Activities, Carbonic Anhydrase I-II Inhibition Properties, and In Silico Studies.咪唑衍生的烷基和芳基醚:合成、表征、体外抗癌和抗氧化活性、碳酸酐酶I-II抑制特性及计算机模拟研究
ACS Omega. 2024 May 3;9(19):20937-20956. doi: 10.1021/acsomega.4c00028. eCollection 2024 May 14.
9
Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.靶向VEGFR-2酶的新型三唑并[3,4-a]酞嗪衍生物的设计、合成、体外抗癌活性、ADMET特性及分子对接
Anticancer Agents Med Chem. 2018;18(8):1184-1196. doi: 10.2174/1871520618666180412123833.
10
Novel dihydrobenzofuran derivatives: design, synthesis, cytotoxic activity, apoptosis, molecular modelling and DNA binding studies.新型二氢苯并呋喃衍生物的设计、合成、细胞毒性活性、细胞凋亡、分子模拟及 DNA 结合研究。
J Biomol Struct Dyn. 2024;42(23):12742-12760. doi: 10.1080/07391102.2023.2273431. Epub 2023 Oct 30.

本文引用的文献

1
Metochalcone induces senescence-associated secretory phenotype via JAK2/STAT3 pathway in breast cancer.介壳素通过 JAK2/STAT3 通路诱导乳腺癌衰老相关分泌表型。
Oncol Res. 2024 Apr 23;32(5):943-953. doi: 10.32604/or.2023.044775. eCollection 2024.
2
Design, synthesis, docking, and antiviral evaluation of some novel pyrimidinone-based α-aminophosphonates as potent H1N1 and HCoV-229E inhibitors.基于嘧啶酮的新型 α-氨基膦酸酯的设计、合成、对接及作为强效 H1N1 和 HCoV-229E 抑制剂的抗病毒活性评价。
Bioorg Chem. 2024 Jun;147:107353. doi: 10.1016/j.bioorg.2024.107353. Epub 2024 Apr 8.
3
Simple dihydropyridine-based colorimetric chemosensors for heavy metal ion detection, biological evaluation, molecular docking, and ADMET profiling.
基于二氢吡啶的简单比色化学传感器用于重金属离子检测、生物评价、分子对接和 ADMET 分析。
Sci Rep. 2023 Sep 18;13(1):15420. doi: 10.1038/s41598-023-42137-7.
4
Discovery of dioxo-benzo[b]thiophene derivatives as potent YAP-TEAD interaction inhibitors for treating breast cancer.发现二氧代苯并[b]噻吩衍生物作为治疗乳腺癌的有效YAP-TEAD相互作用抑制剂。
Bioorg Chem. 2023 Feb;131:106274. doi: 10.1016/j.bioorg.2022.106274. Epub 2022 Nov 16.
5
Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020.全球及中国癌症负担的变化趋势:对《2020年全球癌症统计数据》的二次分析
Chin Med J (Engl). 2021 Mar 17;134(7):783-791. doi: 10.1097/CM9.0000000000001474.
6
Biomedical Applications of Aromatic Azo Compounds.芳香偶氮化合物在生物医学中的应用。
Mini Rev Med Chem. 2018;18(18):1548-1558. doi: 10.2174/1389557518666180524113111.
7
Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1.维替泊芬的肿瘤选择性蛋白毒性独立于YAP1抑制结肠癌进展。
Sci Signal. 2015 Oct 6;8(397):ra98. doi: 10.1126/scisignal.aac5418.
8
The Hippo pathway in chemotherapeutic drug resistance.化疗耐药中的河马通路。
Int J Cancer. 2015 Dec 15;137(12):2767-73. doi: 10.1002/ijc.29293. Epub 2014 Nov 8.
9
Pharmacological characteristics of metamizole.安乃近的药理学特性。
Pol J Vet Sci. 2014;17(1):207-14. doi: 10.2478/pjvs-2014-0030.
10
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP.遗传和药理学破坏 TEAD-YAP 复合物可抑制 YAP 的致癌活性。
Genes Dev. 2012 Jun 15;26(12):1300-5. doi: 10.1101/gad.192856.112. Epub 2012 Jun 7.